Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

BACKGROUND: Results of small-scale studies have suggested that stem-cell therapy is safe and effective in patients with liver cirrhosis, but no adequately powered randomised controlled trials have been done. We assessed the safety and efficacy of granulocyte colony-stimulating factor (G-CSF) and hae...

Descripción completa

Detalles Bibliográficos
Autores principales: Newsome, Philip Noel, Fox, Richard, King, Andrew L, Barton, Darren, Than, Nwe-Ni, Moore, Joanna, Corbett, Christopher, Townsend, Sarah, Thomas, James, Guo, Kathy, Hull, Diana, Beard, Heather A, Thompson, Jacqui, Atkinson, Anne, Bienek, Carol, McGowan, Neil, Guha, Neil, Campbell, John, Hollyman, Dan, Stocken, Deborah, Yap, Christina, Forbes, Stuart John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738975/
https://www.ncbi.nlm.nih.gov/pubmed/29127060
http://dx.doi.org/10.1016/S2468-1253(17)30326-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738975/
https://www.ncbi.nlm.nih.gov/pubmed/29127060
http://dx.doi.org/10.1016/S2468-1253(17)30326-6

Ejemplares similares